nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Capecitabine—stomach cancer	0.0592	0.415	CbGbCtD
Guanfacine—CYP2C9—Fluorouracil—stomach cancer	0.0351	0.246	CbGbCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—stomach cancer	0.0235	1	CbGdCrCtD
Guanfacine—CYP3A4—Irinotecan—stomach cancer	0.0213	0.149	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—stomach cancer	0.0156	0.109	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—stomach cancer	0.0116	0.0814	CbGbCtD
Guanfacine—Diclofenac—ALOX5—stomach cancer	0.0067	0.438	CrCbGaD
Guanfacine—Diclofenac—CXCL8—stomach cancer	0.00555	0.362	CrCbGaD
Guanfacine—Diclofenac—PTGS2—stomach cancer	0.00162	0.106	CrCbGaD
Guanfacine—Diclofenac—ALB—stomach cancer	0.00144	0.0942	CrCbGaD
Guanfacine—Palpitations—Docetaxel—stomach cancer	0.00112	0.0016	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—stomach cancer	0.00111	0.0016	CcSEcCtD
Guanfacine—Loss of consciousness—Docetaxel—stomach cancer	0.00111	0.00159	CcSEcCtD
Guanfacine—Malaise—Capecitabine—stomach cancer	0.0011	0.00158	CcSEcCtD
Guanfacine—Vertigo—Capecitabine—stomach cancer	0.0011	0.00158	CcSEcCtD
Guanfacine—Hypersensitivity—Irinotecan—stomach cancer	0.0011	0.00158	CcSEcCtD
Guanfacine—Syncope—Capecitabine—stomach cancer	0.0011	0.00157	CcSEcCtD
Guanfacine—Convulsion—Docetaxel—stomach cancer	0.00109	0.00157	CcSEcCtD
Guanfacine—Hypertension—Docetaxel—stomach cancer	0.00109	0.00157	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—stomach cancer	0.00109	0.00156	CcSEcCtD
Guanfacine—Palpitations—Capecitabine—stomach cancer	0.00108	0.00155	CcSEcCtD
Guanfacine—Myalgia—Docetaxel—stomach cancer	0.00107	0.00154	CcSEcCtD
Guanfacine—Chest pain—Docetaxel—stomach cancer	0.00107	0.00154	CcSEcCtD
Guanfacine—Arthralgia—Docetaxel—stomach cancer	0.00107	0.00154	CcSEcCtD
Guanfacine—Loss of consciousness—Capecitabine—stomach cancer	0.00107	0.00154	CcSEcCtD
Guanfacine—Asthenia—Irinotecan—stomach cancer	0.00107	0.00154	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—stomach cancer	0.00106	0.00152	CcSEcCtD
Guanfacine—Hypertension—Capecitabine—stomach cancer	0.00106	0.00152	CcSEcCtD
Guanfacine—Hypersensitivity—Fluorouracil—stomach cancer	0.00105	0.00151	CcSEcCtD
Guanfacine—Dry mouth—Docetaxel—stomach cancer	0.00105	0.00151	CcSEcCtD
Guanfacine—Sweating—Epirubicin—stomach cancer	0.00104	0.0015	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—stomach cancer	0.00104	0.0015	CcSEcCtD
Guanfacine—Chest pain—Capecitabine—stomach cancer	0.00104	0.00149	CcSEcCtD
Guanfacine—Arthralgia—Capecitabine—stomach cancer	0.00104	0.00149	CcSEcCtD
Guanfacine—Myalgia—Capecitabine—stomach cancer	0.00104	0.00149	CcSEcCtD
Guanfacine—Confusional state—Docetaxel—stomach cancer	0.00104	0.00149	CcSEcCtD
Guanfacine—Anxiety—Capecitabine—stomach cancer	0.00104	0.00149	CcSEcCtD
Guanfacine—Oedema—Docetaxel—stomach cancer	0.00103	0.00148	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—stomach cancer	0.00103	0.00148	CcSEcCtD
Guanfacine—Discomfort—Capecitabine—stomach cancer	0.00103	0.00148	CcSEcCtD
Guanfacine—Diarrhoea—Irinotecan—stomach cancer	0.00102	0.00146	CcSEcCtD
Guanfacine—Dry mouth—Capecitabine—stomach cancer	0.00102	0.00146	CcSEcCtD
Guanfacine—Shock—Docetaxel—stomach cancer	0.00101	0.00146	CcSEcCtD
Guanfacine—Pruritus—Fluorouracil—stomach cancer	0.00101	0.00145	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—stomach cancer	0.00101	0.00145	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—stomach cancer	0.00101	0.00145	CcSEcCtD
Guanfacine—Confusional state—Capecitabine—stomach cancer	0.00101	0.00144	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—stomach cancer	0.00101	0.00144	CcSEcCtD
Guanfacine—Oedema—Capecitabine—stomach cancer	0.000997	0.00143	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—stomach cancer	0.000996	0.00143	CcSEcCtD
Guanfacine—Dizziness—Irinotecan—stomach cancer	0.000986	0.00142	CcSEcCtD
Guanfacine—Shock—Capecitabine—stomach cancer	0.000981	0.00141	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—stomach cancer	0.000981	0.00141	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—stomach cancer	0.00098	0.00141	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—stomach cancer	0.000977	0.0014	CcSEcCtD
Guanfacine—Diarrhoea—Fluorouracil—stomach cancer	0.000977	0.0014	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—stomach cancer	0.000974	0.0014	CcSEcCtD
Guanfacine—Tachycardia—Capecitabine—stomach cancer	0.000973	0.0014	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—stomach cancer	0.000966	0.00139	CcSEcCtD
Guanfacine—Hyperhidrosis—Capecitabine—stomach cancer	0.000964	0.00138	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—stomach cancer	0.000963	0.00138	CcSEcCtD
Guanfacine—Vomiting—Irinotecan—stomach cancer	0.000948	0.00136	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—stomach cancer	0.000944	0.00136	CcSEcCtD
Guanfacine—Dizziness—Fluorouracil—stomach cancer	0.000944	0.00136	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—stomach cancer	0.000943	0.00135	CcSEcCtD
Guanfacine—Rash—Irinotecan—stomach cancer	0.00094	0.00135	CcSEcCtD
Guanfacine—Dermatitis—Irinotecan—stomach cancer	0.000939	0.00135	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000939	0.00135	CcSEcCtD
Guanfacine—Headache—Irinotecan—stomach cancer	0.000934	0.00134	CcSEcCtD
Guanfacine—Hypotension—Capecitabine—stomach cancer	0.000932	0.00134	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—stomach cancer	0.000932	0.00134	CcSEcCtD
Guanfacine—Paraesthesia—Docetaxel—stomach cancer	0.000925	0.00133	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—stomach cancer	0.000924	0.00133	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—stomach cancer	0.000921	0.00132	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—stomach cancer	0.000918	0.00132	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—stomach cancer	0.000916	0.00132	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—stomach cancer	0.000914	0.00131	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—stomach cancer	0.000912	0.00131	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000909	0.00131	CcSEcCtD
Guanfacine—Vomiting—Fluorouracil—stomach cancer	0.000908	0.0013	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—stomach cancer	0.000907	0.0013	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—stomach cancer	0.000907	0.0013	CcSEcCtD
Guanfacine—Insomnia—Capecitabine—stomach cancer	0.000902	0.0013	CcSEcCtD
Guanfacine—Rash—Fluorouracil—stomach cancer	0.0009	0.00129	CcSEcCtD
Guanfacine—Dermatitis—Fluorouracil—stomach cancer	0.000899	0.00129	CcSEcCtD
Guanfacine—Paraesthesia—Capecitabine—stomach cancer	0.000896	0.00129	CcSEcCtD
Guanfacine—Decreased appetite—Docetaxel—stomach cancer	0.000896	0.00129	CcSEcCtD
Guanfacine—Headache—Fluorouracil—stomach cancer	0.000894	0.00128	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—stomach cancer	0.000891	0.00128	CcSEcCtD
Guanfacine—Dyspnoea—Capecitabine—stomach cancer	0.000889	0.00128	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—stomach cancer	0.000888	0.00128	CcSEcCtD
Guanfacine—Nausea—Irinotecan—stomach cancer	0.000885	0.00127	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—stomach cancer	0.000883	0.00127	CcSEcCtD
Guanfacine—Constipation—Docetaxel—stomach cancer	0.000881	0.00127	CcSEcCtD
Guanfacine—Dyspepsia—Capecitabine—stomach cancer	0.000878	0.00126	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—stomach cancer	0.000872	0.00125	CcSEcCtD
Guanfacine—Decreased appetite—Capecitabine—stomach cancer	0.000867	0.00125	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—stomach cancer	0.000864	0.00124	CcSEcCtD
Guanfacine—Fatigue—Capecitabine—stomach cancer	0.00086	0.00124	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—stomach cancer	0.000857	0.00123	CcSEcCtD
Guanfacine—Constipation—Capecitabine—stomach cancer	0.000853	0.00123	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—stomach cancer	0.000849	0.00122	CcSEcCtD
Guanfacine—Nausea—Fluorouracil—stomach cancer	0.000848	0.00122	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—stomach cancer	0.000846	0.00121	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—stomach cancer	0.000844	0.00121	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—stomach cancer	0.000844	0.00121	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000842	0.00121	CcSEcCtD
Guanfacine—Tension—Epirubicin—stomach cancer	0.000835	0.0012	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—stomach cancer	0.000834	0.0012	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—stomach cancer	0.000827	0.00119	CcSEcCtD
Guanfacine—Feeling abnormal—Capecitabine—stomach cancer	0.000822	0.00118	CcSEcCtD
Guanfacine—Malaise—Methotrexate—stomach cancer	0.00082	0.00118	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—stomach cancer	0.000819	0.00118	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—stomach cancer	0.000817	0.00117	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—stomach cancer	0.000817	0.00117	CcSEcCtD
Guanfacine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000816	0.00117	CcSEcCtD
Guanfacine—Abdominal pain—Docetaxel—stomach cancer	0.000814	0.00117	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—stomach cancer	0.000802	0.00115	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—stomach cancer	0.0008	0.00115	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—stomach cancer	0.00079	0.00113	CcSEcCtD
Guanfacine—Abdominal pain—Capecitabine—stomach cancer	0.000788	0.00113	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—stomach cancer	0.000788	0.00113	CcSEcCtD
Guanfacine—Agitation—Epirubicin—stomach cancer	0.000782	0.00112	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—stomach cancer	0.000775	0.00111	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—stomach cancer	0.000775	0.00111	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—stomach cancer	0.000775	0.00111	CcSEcCtD
Guanfacine—Tension—Doxorubicin—stomach cancer	0.000773	0.00111	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—stomach cancer	0.000771	0.00111	CcSEcCtD
Guanfacine—Malaise—Epirubicin—stomach cancer	0.000768	0.0011	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—stomach cancer	0.000765	0.0011	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—stomach cancer	0.000765	0.0011	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—stomach cancer	0.000765	0.0011	CcSEcCtD
Guanfacine—Syncope—Epirubicin—stomach cancer	0.000764	0.0011	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—stomach cancer	0.000759	0.00109	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—stomach cancer	0.000757	0.00109	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—stomach cancer	0.000752	0.00108	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—stomach cancer	0.000749	0.00108	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—stomach cancer	0.000748	0.00107	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—stomach cancer	0.000742	0.00107	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—stomach cancer	0.000739	0.00106	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—stomach cancer	0.000738	0.00106	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—stomach cancer	0.000735	0.00106	CcSEcCtD
Guanfacine—Hypersensitivity—Capecitabine—stomach cancer	0.000735	0.00106	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000731	0.00105	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—stomach cancer	0.000729	0.00105	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—stomach cancer	0.000725	0.00104	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—stomach cancer	0.000725	0.00104	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—stomach cancer	0.000725	0.00104	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—stomach cancer	0.000724	0.00104	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—stomach cancer	0.000722	0.00104	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—stomach cancer	0.000718	0.00103	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—stomach cancer	0.000716	0.00103	CcSEcCtD
Guanfacine—Asthenia—Capecitabine—stomach cancer	0.000716	0.00103	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—stomach cancer	0.00071	0.00102	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—stomach cancer	0.000709	0.00102	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—stomach cancer	0.000708	0.00102	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—stomach cancer	0.000706	0.00101	CcSEcCtD
Guanfacine—Pruritus—Capecitabine—stomach cancer	0.000706	0.00101	CcSEcCtD
Guanfacine—Diarrhoea—Docetaxel—stomach cancer	0.000705	0.00101	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—stomach cancer	0.000701	0.00101	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—stomach cancer	0.000696	0.001	CcSEcCtD
Guanfacine—Oedema—Epirubicin—stomach cancer	0.000695	0.000998	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—stomach cancer	0.000694	0.000997	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—stomach cancer	0.000692	0.000994	CcSEcCtD
Guanfacine—Shock—Epirubicin—stomach cancer	0.000684	0.000982	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—stomach cancer	0.000683	0.00098	CcSEcCtD
Guanfacine—Diarrhoea—Capecitabine—stomach cancer	0.000682	0.00098	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—stomach cancer	0.000681	0.000978	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—stomach cancer	0.00068	0.000977	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—stomach cancer	0.000678	0.000974	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000676	0.000972	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—stomach cancer	0.000672	0.000965	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—stomach cancer	0.000672	0.000965	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—stomach cancer	0.000671	0.000963	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—stomach cancer	0.000671	0.000963	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—stomach cancer	0.000671	0.000963	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—stomach cancer	0.000668	0.00096	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—stomach cancer	0.000667	0.000958	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—stomach cancer	0.000663	0.000952	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—stomach cancer	0.000662	0.000951	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—stomach cancer	0.00066	0.000948	CcSEcCtD
Guanfacine—Dizziness—Capecitabine—stomach cancer	0.00066	0.000947	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—stomach cancer	0.000656	0.000942	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—stomach cancer	0.000655	0.000941	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—stomach cancer	0.000654	0.000939	CcSEcCtD
Guanfacine—Rash—Docetaxel—stomach cancer	0.00065	0.000933	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—stomach cancer	0.000649	0.000933	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—stomach cancer	0.000649	0.000932	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—stomach cancer	0.000648	0.000931	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—stomach cancer	0.000645	0.000927	CcSEcCtD
Guanfacine—Headache—Docetaxel—stomach cancer	0.000645	0.000927	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—stomach cancer	0.000643	0.000923	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—stomach cancer	0.00064	0.000919	CcSEcCtD
Guanfacine—Vomiting—Capecitabine—stomach cancer	0.000634	0.000911	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000633	0.000909	CcSEcCtD
Guanfacine—Shock—Doxorubicin—stomach cancer	0.000633	0.000909	CcSEcCtD
Guanfacine—Rash—Capecitabine—stomach cancer	0.000629	0.000903	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—stomach cancer	0.000628	0.000903	CcSEcCtD
Guanfacine—Dermatitis—Capecitabine—stomach cancer	0.000628	0.000902	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—stomach cancer	0.000628	0.000901	CcSEcCtD
Guanfacine—Headache—Capecitabine—stomach cancer	0.000625	0.000897	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—stomach cancer	0.000624	0.000896	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000622	0.000893	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—stomach cancer	0.00062	0.00089	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—stomach cancer	0.000618	0.000887	CcSEcCtD
Guanfacine—Nausea—Docetaxel—stomach cancer	0.000612	0.000879	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—stomach cancer	0.000612	0.000879	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—stomach cancer	0.000612	0.000879	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000607	0.000872	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—stomach cancer	0.000604	0.000868	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—stomach cancer	0.000601	0.000863	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—stomach cancer	0.000599	0.00086	CcSEcCtD
Guanfacine—Constipation—Epirubicin—stomach cancer	0.000594	0.000853	CcSEcCtD
Guanfacine—Nausea—Capecitabine—stomach cancer	0.000592	0.000851	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—stomach cancer	0.000587	0.000843	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000586	0.000841	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—stomach cancer	0.000582	0.000835	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—stomach cancer	0.000577	0.000829	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—stomach cancer	0.000573	0.000823	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—stomach cancer	0.000573	0.000822	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—stomach cancer	0.000572	0.000821	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000568	0.000816	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—stomach cancer	0.000566	0.000813	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—stomach cancer	0.000559	0.000803	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—stomach cancer	0.000554	0.000796	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—stomach cancer	0.00055	0.00079	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—stomach cancer	0.000549	0.000789	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—stomach cancer	0.000547	0.000786	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—stomach cancer	0.000533	0.000765	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—stomach cancer	0.00053	0.000761	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000526	0.000755	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—stomach cancer	0.000525	0.000755	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—stomach cancer	0.000512	0.000735	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—stomach cancer	0.000508	0.00073	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—stomach cancer	0.000508	0.00073	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—stomach cancer	0.000499	0.000716	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—stomach cancer	0.000492	0.000706	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—stomach cancer	0.000491	0.000705	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—stomach cancer	0.000475	0.000683	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—stomach cancer	0.000474	0.00068	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—stomach cancer	0.000472	0.000678	CcSEcCtD
Guanfacine—Rash—Methotrexate—stomach cancer	0.000468	0.000672	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—stomach cancer	0.000468	0.000672	CcSEcCtD
Guanfacine—Headache—Methotrexate—stomach cancer	0.000465	0.000668	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—stomach cancer	0.000461	0.000663	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—stomach cancer	0.00046	0.00066	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—stomach cancer	0.000455	0.000653	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—stomach cancer	0.000442	0.000635	CcSEcCtD
Guanfacine—Nausea—Methotrexate—stomach cancer	0.000441	0.000633	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—stomach cancer	0.00044	0.000632	CcSEcCtD
Guanfacine—Rash—Epirubicin—stomach cancer	0.000438	0.000629	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—stomach cancer	0.000438	0.000629	CcSEcCtD
Guanfacine—Headache—Epirubicin—stomach cancer	0.000435	0.000625	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—stomach cancer	0.000425	0.000611	CcSEcCtD
Guanfacine—Nausea—Epirubicin—stomach cancer	0.000413	0.000593	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—stomach cancer	0.000409	0.000587	CcSEcCtD
Guanfacine—Rash—Doxorubicin—stomach cancer	0.000405	0.000582	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—stomach cancer	0.000405	0.000582	CcSEcCtD
Guanfacine—Headache—Doxorubicin—stomach cancer	0.000403	0.000579	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—stomach cancer	0.000382	0.000549	CcSEcCtD
Guanfacine—CYP2C9—Metabolism—PDHA1—stomach cancer	5.19e-05	0.000425	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ECHS1—stomach cancer	5.19e-05	0.000425	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—RHOA—stomach cancer	5.18e-05	0.000424	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—NOS3—stomach cancer	5.13e-05	0.00042	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKR1C3—stomach cancer	5.09e-05	0.000417	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RBP4—stomach cancer	5.09e-05	0.000417	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CXCL8—stomach cancer	5.09e-05	0.000416	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPAP2A—stomach cancer	5.07e-05	0.000415	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SREBF2—stomach cancer	5.01e-05	0.00041	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RPS6—stomach cancer	4.96e-05	0.000406	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ENO1—stomach cancer	4.96e-05	0.000406	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—RORA—stomach cancer	4.95e-05	0.000405	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PRKCB—stomach cancer	4.88e-05	0.0004	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TYMP—stomach cancer	4.88e-05	0.000399	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—FADS1—stomach cancer	4.88e-05	0.000399	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—VEGFA—stomach cancer	4.87e-05	0.000399	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6ST—stomach cancer	4.86e-05	0.000398	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALDOB—stomach cancer	4.64e-05	0.00038	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—MAPK3—stomach cancer	4.61e-05	0.000377	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SREBF2—stomach cancer	4.57e-05	0.000374	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HBEGF—stomach cancer	4.56e-05	0.000373	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FBP1—stomach cancer	4.52e-05	0.00037	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA1—stomach cancer	4.52e-05	0.00037	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CKB—stomach cancer	4.52e-05	0.00037	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.52e-05	0.00037	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—RORA—stomach cancer	4.51e-05	0.000369	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CD44—stomach cancer	4.4e-05	0.00036	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—MAPK1—stomach cancer	4.38e-05	0.000359	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	4.38e-05	0.000358	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	4.38e-05	0.000358	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.37e-05	0.000358	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.36e-05	0.000357	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6R—stomach cancer	4.34e-05	0.000355	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BMP2—stomach cancer	4.33e-05	0.000354	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2R—stomach cancer	4.33e-05	0.000354	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—RHOA—stomach cancer	4.32e-05	0.000353	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALOX5—stomach cancer	4.31e-05	0.000353	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	4.26e-05	0.000348	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLIN2—stomach cancer	4.25e-05	0.000347	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—DPYD—stomach cancer	4.24e-05	0.000347	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALDOB—stomach cancer	4.23e-05	0.000346	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	4.21e-05	0.000345	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADRB2—stomach cancer	4.21e-05	0.000344	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—KRAS—stomach cancer	4.14e-05	0.000339	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA2—stomach cancer	4.13e-05	0.000338	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PPP2R1A—stomach cancer	4.12e-05	0.000338	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	4.08e-05	0.000334	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	4.07e-05	0.000333	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NT5E—stomach cancer	4.03e-05	0.000329	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PGAM1—stomach cancer	4.03e-05	0.000329	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.99e-05	0.000326	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.98e-05	0.000326	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	3.94e-05	0.000323	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALOX5—stomach cancer	3.93e-05	0.000322	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—RHOA—stomach cancer	3.92e-05	0.000321	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—DPYD—stomach cancer	3.87e-05	0.000317	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.85e-05	0.000315	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.84e-05	0.000314	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCE1—stomach cancer	3.84e-05	0.000314	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SMAD4—stomach cancer	3.83e-05	0.000313	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—PIK3CA—stomach cancer	3.8e-05	0.000311	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCL8—stomach cancer	3.79e-05	0.00031	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RPS6—stomach cancer	3.77e-05	0.000308	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTT1—stomach cancer	3.75e-05	0.000307	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPP2R1A—stomach cancer	3.74e-05	0.000306	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.71e-05	0.000304	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	3.71e-05	0.000303	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—stomach cancer	3.7e-05	0.000302	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	3.69e-05	0.000302	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—UMPS—stomach cancer	3.68e-05	0.000301	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TP53—stomach cancer	3.68e-05	0.000301	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTP1—stomach cancer	3.67e-05	0.0003	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FYN—stomach cancer	3.64e-05	0.000298	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMOX1—stomach cancer	3.62e-05	0.000296	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.61e-05	0.000295	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—HRAS—stomach cancer	3.52e-05	0.000288	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ENO1—stomach cancer	3.52e-05	0.000288	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.51e-05	0.000287	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK3—stomach cancer	3.5e-05	0.000286	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	3.46e-05	0.000283	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.46e-05	0.000283	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL8—stomach cancer	3.44e-05	0.000282	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PDHA1—stomach cancer	3.42e-05	0.00028	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ECHS1—stomach cancer	3.42e-05	0.00028	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTT1—stomach cancer	3.42e-05	0.00028	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGFR2—stomach cancer	3.41e-05	0.000279	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TYMS—stomach cancer	3.41e-05	0.000279	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.38e-05	0.000277	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTM1—stomach cancer	3.37e-05	0.000276	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK1—stomach cancer	3.33e-05	0.000272	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	3.29e-05	0.000269	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKR1C3—stomach cancer	3.29e-05	0.000269	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	3.28e-05	0.000268	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TYMP—stomach cancer	3.22e-05	0.000263	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FADS1—stomach cancer	3.22e-05	0.000263	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ENO1—stomach cancer	3.21e-05	0.000262	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	3.19e-05	0.000261	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ERCC2—stomach cancer	3.17e-05	0.00026	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.15e-05	0.000258	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—KRAS—stomach cancer	3.14e-05	0.000257	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	3.13e-05	0.000256	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS2—stomach cancer	3.13e-05	0.000256	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD44—stomach cancer	3.12e-05	0.000255	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CAV1—stomach cancer	3.03e-05	0.000248	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.03e-05	0.000248	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—stomach cancer	3.02e-05	0.000247	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SREBF2—stomach cancer	3.01e-05	0.000247	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—stomach cancer	2.98e-05	0.000244	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—RORA—stomach cancer	2.98e-05	0.000244	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	2.97e-05	0.000243	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	2.91e-05	0.000238	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	2.89e-05	0.000236	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	2.88e-05	0.000236	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	2.88e-05	0.000235	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	2.87e-05	0.000235	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD44—stomach cancer	2.84e-05	0.000233	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—stomach cancer	2.79e-05	0.000228	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOB—stomach cancer	2.79e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APC—stomach cancer	2.76e-05	0.000226	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FYN—stomach cancer	2.76e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.76e-05	0.000226	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—stomach cancer	2.75e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—stomach cancer	2.74e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—HRAS—stomach cancer	2.67e-05	0.000219	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.65e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	2.64e-05	0.000216	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	2.61e-05	0.000214	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTP1—stomach cancer	2.6e-05	0.000213	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX5—stomach cancer	2.59e-05	0.000212	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	2.59e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—stomach cancer	2.57e-05	0.00021	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	2.56e-05	0.00021	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—DPYD—stomach cancer	2.55e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	2.52e-05	0.000206	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	2.52e-05	0.000206	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TYMS—stomach cancer	2.42e-05	0.000198	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—stomach cancer	2.42e-05	0.000198	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.42e-05	0.000198	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	2.4e-05	0.000197	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	2.4e-05	0.000196	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—stomach cancer	2.39e-05	0.000196	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	2.38e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	2.37e-05	0.000194	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTP1—stomach cancer	2.37e-05	0.000194	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—stomach cancer	2.34e-05	0.000191	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	2.32e-05	0.000189	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	2.3e-05	0.000188	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	2.29e-05	0.000188	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	2.29e-05	0.000188	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—stomach cancer	2.26e-05	0.000185	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ERCC2—stomach cancer	2.25e-05	0.000184	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.23e-05	0.000183	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TYMS—stomach cancer	2.2e-05	0.00018	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	2.19e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	2.18e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	2.18e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—stomach cancer	2.18e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—stomach cancer	2.17e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.17e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	2.14e-05	0.000175	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—stomach cancer	2.11e-05	0.000173	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—stomach cancer	2.11e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APC—stomach cancer	2.09e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—stomach cancer	2.08e-05	0.00017	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ERCC2—stomach cancer	2.05e-05	0.000168	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	2.03e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	2.02e-05	0.000165	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	2.01e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	1.99e-05	0.000162	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—stomach cancer	1.95e-05	0.000159	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	1.94e-05	0.000159	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—stomach cancer	1.94e-05	0.000159	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	1.93e-05	0.000158	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—stomach cancer	1.93e-05	0.000158	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	1.91e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	1.91e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—stomach cancer	1.9e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	1.89e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JUN—stomach cancer	1.89e-05	0.000155	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD44—stomach cancer	1.88e-05	0.000153	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.86e-05	0.000152	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	1.84e-05	0.00015	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	1.83e-05	0.00015	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.82e-05	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	1.82e-05	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	1.8e-05	0.000148	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	1.79e-05	0.000146	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—stomach cancer	1.78e-05	0.000145	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—stomach cancer	1.77e-05	0.000145	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	1.76e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.74e-05	0.000142	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—stomach cancer	1.71e-05	0.00014	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.7e-05	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.66e-05	0.000136	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	1.65e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	1.63e-05	0.000134	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	1.63e-05	0.000133	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.59e-05	0.00013	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTP1—stomach cancer	1.56e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.56e-05	0.000128	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—stomach cancer	1.56e-05	0.000128	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—stomach cancer	1.54e-05	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.54e-05	0.000126	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—stomach cancer	1.54e-05	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.53e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.52e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.51e-05	0.000123	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.49e-05	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.49e-05	0.000122	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—stomach cancer	1.47e-05	0.000121	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.47e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TYMS—stomach cancer	1.45e-05	0.000119	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—stomach cancer	1.44e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.44e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.43e-05	0.000117	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—stomach cancer	1.4e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.4e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.4e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.39e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.36e-05	0.000111	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ERCC2—stomach cancer	1.35e-05	0.000111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—stomach cancer	1.35e-05	0.00011	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—stomach cancer	1.34e-05	0.00011	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.29e-05	0.000106	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—stomach cancer	1.27e-05	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.25e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.25e-05	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.24e-05	0.000102	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—stomach cancer	1.23e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.19e-05	9.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.19e-05	9.7e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—stomach cancer	1.17e-05	9.59e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.17e-05	9.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—stomach cancer	1.17e-05	9.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.15e-05	9.43e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.14e-05	9.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.13e-05	9.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.13e-05	9.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.06e-05	8.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—stomach cancer	1.03e-05	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	9.78e-06	8.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—stomach cancer	9.47e-06	7.75e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—stomach cancer	9.26e-06	7.58e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	9.05e-06	7.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—stomach cancer	8.86e-06	7.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—stomach cancer	8.66e-06	7.09e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—stomach cancer	8.29e-06	6.78e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—stomach cancer	8.1e-06	6.63e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—stomach cancer	7.56e-06	6.19e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.99e-06	4.08e-05	CbGpPWpGaD
